August 25 Media Roundup

Comments

Join us at Medidata Symposium in Phoenix Oct. 17-19.

The previously unimaginable is now within grasp: How AI, machine learning and tech help treat burn victims.

Eight-armed surgeon? This futuristic robotic octopus could one day be used in surgery or for space exploration.

Nanodaisies and DNA cocoons.

Will humans colonize outer space? Will we ever cure Alzheimer’s? Top scientists predict the future.

A three-year wait: Disease modeling explains why it’s so difficult to declare countries polio-free.

Is perfect still the enemy of good? Experts convene to reform organ donation.

UMass researchers test wearable swallowable tech to help study opioid addiction.

A virtual reality program to teach autism patients how to drive.

Genetic tests for cancer don’t always have the answer.

Viruses are more dangerous if they infect patients in the morning.

“My holy grail is instant diagnosis and instant cure.”

Neural dust sensors could power prosthetics and monitor disease.

Beautiful & inspiring: family rallies to fund research for experimental gene therapy for Sanfilippo syndrome.

Housing data collected from more than 60,000 people in Broad Institute project has huge clinical research potential.

By using genetic materials to “bar-code” individual brain cells, neuroscientists are working to map the connections between neurons in the brain. This new technique, called MAP-seq, may help researchers gain new insight into neurological disorders like autism and schizophrenia.

Turning back the clock: gene therapy may help L-Dopa work again in patients with advanced Parkinson’s.

Can artificial intelligence identify patients with mental illness?

From digestible batteries to robots you can swallow, researchers are working to develop edible electronic devices with the potential to diagnose and treat disease. Using naturally-occurring melanin pigments, researchers from Carnegie Mellon University have developed small edible batters to power swallowable devices, while researchers from the Polytechnique Montréal have developed tiny “nanobots” that can travel through the bloodstream and target active cancerous cells.

Follow us on Twitter and LinkedIn for the latest in how technology is transforming life sciences.

About Author

Geeks Talk Clinical